Susceptibilities of Neonatal Respiratory Isolates of Ureaplasma urealyticum to Antimicrobial Agents | Zendy

Anne Matlow | Zendy; Cecilia Th’ng | Zendy; Danuta Kovach | Zendy; Patricia A. Quinn | Zendy; Michael Dunn | Zendy; Elaine Wang | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Susceptibilities of Neonatal Respiratory Isolates of Ureaplasma urealyticum to Antimicrobial Agents

Author(s) -

Anne Matlow,

Cecilia Th’ng,

Danuta Kovach,

Patricia A. Quinn,

Michael Dunn,

Elaine Wang

Publication year - 1998

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.42.5.1290

Subject(s) - ureaplasma urealyticum , doxycycline , azithromycin , erythromycin , ureaplasma , microbiology and biotechnology , ciprofloxacin , antibiotics , medicine , antibacterial agent , antimicrobial , gentamicin , biology , mycoplasma

Twenty-one neonatal respiratory isolates ofUreaplasma urealyticum were serotyped, and their susceptibilities to ciprofloxacin, gentamicin, chloramphenicol, erythromycin, azithromycin, and doxycycline were tested. Most patient strains wereUreaplasma urealyticum bv. parvum. Chloramphenicol, doxycycline, and azithromycin had the lowest MICs. This data may be useful when designing prophylactic or therapeutic trials of antibiotics for chronic lung disease of the newborn.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research